Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Oct 26;83(10):1360–1366. doi: 10.1054/bjoc.2000.1440

Effect of c-Abl tyrosine kinase on the cellular response to paclitaxel-induced microtubule damage

A Nehmé 1, B L Lee 2, R Baskaran 3, Q Zhang 1, X Lin 1, R D Christen 1
PMCID: PMC2408779  PMID: 11044362

Abstract

DNA damage has been shown to activate c-Abl tyrosine kinase. We now report that, in addition to DNA damage, microtubule damage induced by paclitaxel results in activation of c-Abl kinase. In 3T3 cells, the presence of c-Abl kinase increased paclitaxel-induced cell death. In Abl-proficient cells, paclitaxel produced a marked and prolonged G2/M arrest which peaked at 24 h and a rapid and marked induction of p21WAF1which also peaked at 24 h. In Abl-deficient cells, the G2/M arrest induced by paclitaxel was less prominent and shorter in duration and the effect of paclitaxel on p21WAF1expression was reduced and delayed. Paclitaxel had no effect on p53 expression and MAPK phosphorylation. These findings indicate that, in 3T3 cells, c-Abl kinase facilitates cell death and regulates G2/M arrest in response to paclitaxel-induced microtubule damage in a pathway that is dependent on p21WAF1and independent of MAPK activity. © 2000 Cancer Research Campaign

Keywords: c-Abl tyrosine kinase, paclitaxel, p21WAF1, p53, cell cycle

Full Text

The Full Text of this article is available as a PDF (112.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akashi M., Hachiya M., Osawa Y., Spirin K., Suzuki G., Koeffler H. P. Irradiation induces WAF1 expression through a p53-independent pathway in KG-1 cells. J Biol Chem. 1995 Aug 11;270(32):19181–19187. doi: 10.1074/jbc.270.32.19181. [DOI] [PubMed] [Google Scholar]
  2. Baskaran R., Chiang G. G., Wang J. Y. Identification of a binding site in c-Ab1 tyrosine kinase for the C-terminal repeated domain of RNA polymerase II. Mol Cell Biol. 1996 Jul;16(7):3361–3369. doi: 10.1128/mcb.16.7.3361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baskaran R., Wood L. D., Whitaker L. L., Canman C. E., Morgan S. E., Xu Y., Barlow C., Baltimore D., Wynshaw-Boris A., Kastan M. B. Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature. 1997 May 29;387(6632):516–519. doi: 10.1038/387516a0. [DOI] [PubMed] [Google Scholar]
  4. Blagosklonny M. V., Schulte T. W., Nguyen P., Mimnaugh E. G., Trepel J., Neckers L. Taxol induction of p21WAF1 and p53 requires c-raf-1. Cancer Res. 1995 Oct 15;55(20):4623–4626. [PubMed] [Google Scholar]
  5. Cabral F., Barlow S. B. Resistance to antimitotic agents as genetic probes of microtubule structure and function. Pharmacol Ther. 1991 Nov;52(2):159–171. doi: 10.1016/0163-7258(91)90006-8. [DOI] [PubMed] [Google Scholar]
  6. Datto M. B., Li Y., Panus J. F., Howe D. J., Xiong Y., Wang X. F. Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5545–5549. doi: 10.1073/pnas.92.12.5545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dean P. N., Jett J. H. Mathematical analysis of DNA distributions derived from flow microfluorometry. J Cell Biol. 1974 Feb;60(2):523–527. doi: 10.1083/jcb.60.2.523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ding A., Chen B., Fuortes M., Blum E. Association of mitogen-activated protein kinases with microtubules in mouse macrophages. J Exp Med. 1996 Apr 1;183(4):1899–1904. doi: 10.1084/jem.183.4.1899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Esposito F., Cuccovillo F., Vanoni M., Cimino F., Anderson C. W., Appella E., Russo T. Redox-mediated regulation of p21(waf1/cip1) expression involves a post-transcriptional mechanism and activation of the mitogen-activated protein kinase pathway. Eur J Biochem. 1997 May 1;245(3):730–737. doi: 10.1111/j.1432-1033.1997.00730.x. [DOI] [PubMed] [Google Scholar]
  10. Fan W. Possible mechanisms of paclitaxel-induced apoptosis. Biochem Pharmacol. 1999 Jun 1;57(11):1215–1221. doi: 10.1016/s0006-2952(99)00006-4. [DOI] [PubMed] [Google Scholar]
  11. Goga A., Liu X., Hambuch T. M., Senechal K., Major E., Berk A. J., Witte O. N., Sawyers C. L. p53 dependent growth suppression by the c-Abl nuclear tyrosine kinase. Oncogene. 1995 Aug 17;11(4):791–799. [PubMed] [Google Scholar]
  12. Haldar S., Basu A., Croce C. M. Bcl2 is the guardian of microtubule integrity. Cancer Res. 1997 Jan 15;57(2):229–233. [PubMed] [Google Scholar]
  13. Harper J. W., Adami G. R., Wei N., Keyomarsi K., Elledge S. J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 1993 Nov 19;75(4):805–816. doi: 10.1016/0092-8674(93)90499-g. [DOI] [PubMed] [Google Scholar]
  14. Horwitz S. B., Cohen D., Rao S., Ringel I., Shen H. J., Yang C. P. Taxol: mechanisms of action and resistance. J Natl Cancer Inst Monogr. 1993;(15):55–61. [PubMed] [Google Scholar]
  15. Hunter T., Pines J. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell. 1994 Nov 18;79(4):573–582. doi: 10.1016/0092-8674(94)90543-6. [DOI] [PubMed] [Google Scholar]
  16. Kharbanda S., Pandey P., Ren R., Mayer B., Zon L., Kufe D. c-Abl activation regulates induction of the SEK1/stress-activated protein kinase pathway in the cellular response to 1-beta-D-arabinofuranosylcytosine. J Biol Chem. 1995 Dec 22;270(51):30278–30281. doi: 10.1074/jbc.270.51.30278. [DOI] [PubMed] [Google Scholar]
  17. Kharbanda S., Ren R., Pandey P., Shafman T. D., Feller S. M., Weichselbaum R. R., Kufe D. W. Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature. 1995 Aug 31;376(6543):785–788. doi: 10.1038/376785a0. [DOI] [PubMed] [Google Scholar]
  18. Kharbanda S., Yuan Z. M., Weichselbaum R., Kufe D. Determination of cell fate by c-Abl activation in the response to DNA damage. Oncogene. 1998 Dec 24;17(25):3309–3318. doi: 10.1038/sj.onc.1202571. [DOI] [PubMed] [Google Scholar]
  19. Kipreos E. T., Wang J. Y. Cell cycle-regulated binding of c-Abl tyrosine kinase to DNA. Science. 1992 Apr 17;256(5055):382–385. doi: 10.1126/science.256.5055.382. [DOI] [PubMed] [Google Scholar]
  20. Lavelle F., Bissery M. C., Combeau C., Riou J. F., Vrignaud P., André S. Preclinical evaluation of docetaxel (Taxotere). Semin Oncol. 1995 Apr;22(2 Suppl 4):3–16. [PubMed] [Google Scholar]
  21. Liu Z. G., Baskaran R., Lea-Chou E. T., Wood L. D., Chen Y., Karin M., Wang J. Y. Three distinct signalling responses by murine fibroblasts to genotoxic stress. Nature. 1996 Nov 21;384(6606):273–276. doi: 10.1038/384273a0. [DOI] [PubMed] [Google Scholar]
  22. Monks A., Scudiero D., Skehan P., Shoemaker R., Paull K., Vistica D., Hose C., Langley J., Cronise P., Vaigro-Wolff A. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst. 1991 Jun 5;83(11):757–766. doi: 10.1093/jnci/83.11.757. [DOI] [PubMed] [Google Scholar]
  23. Nehmé A., Baskaran R., Aebi S., Fink D., Nebel S., Cenni B., Wang J. Y., Howell S. B., Christen R. D. Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells exposed to cisplatin. Cancer Res. 1997 Aug 1;57(15):3253–3257. [PubMed] [Google Scholar]
  24. Nicholson D. W., Ali A., Thornberry N. A., Vaillancourt J. P., Ding C. K., Gallant M., Gareau Y., Griffin P. R., Labelle M., Lazebnik Y. A. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 1995 Jul 6;376(6535):37–43. doi: 10.1038/376037a0. [DOI] [PubMed] [Google Scholar]
  25. Schimming R., Mason K. A., Hunter N., Weil M., Kishi K., Milas L. Lack of correlation between mitotic arrest or apoptosis and antitumor effect of docetaxel. Cancer Chemother Pharmacol. 1999;43(2):165–172. doi: 10.1007/s002800050879. [DOI] [PubMed] [Google Scholar]
  26. Shafman T., Khanna K. K., Kedar P., Spring K., Kozlov S., Yen T., Hobson K., Gatei M., Zhang N., Watters D. Interaction between ATM protein and c-Abl in response to DNA damage. Nature. 1997 May 29;387(6632):520–523. doi: 10.1038/387520a0. [DOI] [PubMed] [Google Scholar]
  27. Shapiro G. I., Harper J. W. Anticancer drug targets: cell cycle and checkpoint control. J Clin Invest. 1999 Dec;104(12):1645–1653. doi: 10.1172/JCI9054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sheikh M. S., Li X. S., Chen J. C., Shao Z. M., Ordonez J. V., Fontana J. A. Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. Oncogene. 1994 Dec;9(12):3407–3415. [PubMed] [Google Scholar]
  29. Shtil A. A., Mandlekar S., Yu R., Walter R. J., Hagen K., Tan T. H., Roninson I. B., Kong A. N. Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cells. Oncogene. 1999 Jan 14;18(2):377–384. doi: 10.1038/sj.onc.1202305. [DOI] [PubMed] [Google Scholar]
  30. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J. T., Bokesch H., Kenney S., Boyd M. R. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst. 1990 Jul 4;82(13):1107–1112. doi: 10.1093/jnci/82.13.1107. [DOI] [PubMed] [Google Scholar]
  31. Stewart Z. A., Mays D., Pietenpol J. A. Defective G1-S cell cycle checkpoint function sensitizes cells to microtubule inhibitor-induced apoptosis. Cancer Res. 1999 Aug 1;59(15):3831–3837. [PubMed] [Google Scholar]
  32. Wang J. Y. Abl tyrosine kinase in signal transduction and cell-cycle regulation. Curr Opin Genet Dev. 1993 Feb;3(1):35–43. doi: 10.1016/s0959-437x(05)80338-7. [DOI] [PubMed] [Google Scholar]
  33. Wang T. H., Wang H. S., Ichijo H., Giannakakou P., Foster J. S., Fojo T., Wimalasena J. Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways. J Biol Chem. 1998 Feb 27;273(9):4928–4936. doi: 10.1074/jbc.273.9.4928. [DOI] [PubMed] [Google Scholar]
  34. Wang W., Furneaux H., Cheng H., Caldwell M. C., Hutter D., Liu Y., Holbrook N., Gorospe M. HuR regulates p21 mRNA stabilization by UV light. Mol Cell Biol. 2000 Feb;20(3):760–769. doi: 10.1128/mcb.20.3.760-769.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Welch P. J., Wang J. Y. A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell. 1993 Nov 19;75(4):779–790. doi: 10.1016/0092-8674(93)90497-e. [DOI] [PubMed] [Google Scholar]
  36. Yuan Z. M., Huang Y., Whang Y., Sawyers C., Weichselbaum R., Kharbanda S., Kufe D. Role for c-Abl tyrosine kinase in growth arrest response to DNA damage. Nature. 1996 Jul 18;382(6588):272–274. doi: 10.1038/382272a0. [DOI] [PubMed] [Google Scholar]
  37. el-Deiry W. S., Tokino T., Velculescu V. E., Levy D. B., Parsons R., Trent J. M., Lin D., Mercer W. E., Kinzler K. W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 1993 Nov 19;75(4):817–825. doi: 10.1016/0092-8674(93)90500-p. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES